Literature DB >> 29498540

Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Hiroto Takahashi1, Yoshiyuki Watanabe1, Hisashi Tanaka1, Masahito Mihara2, Hideki Mochizuki2, Tian Liu3, Yi Wang4, Noriyuki Tomiyama1.   

Abstract

OBJECTIVE: To quantify nigral changes with a focus on their spatial variation within the substantia nigra pars compacta (SNpc) for diagnosing early-stage Parkinson's disease (PD).
METHODS: The study participants were 18 patients with early-stage PD (PD group) and 18 healthy controls (HC group) who underwent quantitative susceptibility mapping (QSM) and neuromelanin imaging. The QSM and neuromelanin values in each whole SNpc containing the entire nigrosome and dorsolateral SNpc containing nigrosome 1 were calculated. The neuromelanin area was defined as the volume with a signal-to-noise ratio higher than that of the background region. The significance of intergroup differences in the QSM value and neuromelanin area in each SNpc region was tested. Logit (p) was used to estimate the probability of PD in relation to the QSM value and the neuromelanin area, and receiver operating characteristic analyses were performed for each value.
RESULTS: In both SNpc, QSM values were significantly higher and neuromelanin areas were significantly lower in the PD group compared with the HC group (p < 0.05). The respective areas under the receiver operating characteristic curve for the two groups were 0.70/0.73 for the QSM value, 0.81/0.78 for the neuromelanin area in the whole/dorsolateral SNpc, and 0.86 for logit (p) in relation to the QSM value of the dorsolateral SNpc and the neuromelanin area of the whole SNpc.
CONCLUSION: Comprehensive MRI assessment of the abnormality involving the nigrosomes can yield a high diagnostic performance for early-stage PD. Advances in knowledge: Focusing on spatial differences in nigral changes within the SNpc can increase the sensitivity of the detection of PD-related neurodegenerative changes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29498540      PMCID: PMC6223299          DOI: 10.1259/bjr.20180037

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  38 in total

1.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

3.  fMRI of the brainstem using dual-echo EPI.

Authors:  Florian Beissner; Ralf Deichmann; Simon Baudrexel
Journal:  Neuroimage       Date:  2011-01-20       Impact factor: 6.556

4.  Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.

Authors:  Dae-Hyuk Kwon; Jong-Min Kim; Se-Hong Oh; Hye-Jin Jeong; Sung-Yeon Park; Eung-Seok Oh; Je-Geun Chi; Young-Bo Kim; Beom S Jeon; Zang-Hee Cho
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

5.  Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.

Authors:  S Reimão; S Ferreira; R G Nunes; P Pita Lobo; D Neutel; D Abreu; N Gonçalves; J Campos; J J Ferreira
Journal:  Eur J Neurol       Date:  2015-10-31       Impact factor: 6.089

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease.

Authors:  D M Mann; P O Yates
Journal:  Mech Ageing Dev       Date:  1983-02       Impact factor: 5.432

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.

Authors:  Stefan T Schwarz; Mohammed Afzal; Paul S Morgan; Nin Bajaj; Penny A Gowland; Dorothee P Auer
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

View more
  8 in total

1.  Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Donghyun Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Jae Hyoung Kim
Journal:  Eur Radiol       Date:  2020-09-04       Impact factor: 5.315

2.  The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Authors:  Xiangming Wang; Yuehui Zhang; Chen Zhu; Guangzong Li; Jie Kang; Fang Chen; Ling Yang
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

3.  Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.

Authors:  Xue Ling Liu; Li Qin Yang; Feng Tao Liu; Pu-Yeh Wu; Yong Zhang; Han Zhuang; Yong Hong Shi; Jian Wang; Dao Ying Geng; Yu Xin Li
Journal:  BMC Neurol       Date:  2020-06-30       Impact factor: 2.474

4.  Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.

Authors:  Apoorva Safai; Shweta Prasad; Tanay Chougule; Jitender Saini; Pramod K Pal; Madhura Ingalhalikar
Journal:  Hum Brain Mapp       Date:  2019-11-28       Impact factor: 5.038

5.  Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra.

Authors:  Gašper Zupan; Dušan Šuput; Zvezdan Pirtošek; Andrej Vovk
Journal:  Brain Sci       Date:  2019-11-22

6.  Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson's Disease.

Authors:  Mengdi Wang; Hongxia Wang; Jing Wang; Shujun Lu; Chen Li; Xiaofei Zhong; Nan Wang; Ruli Ge; Qi Zheng; Jinbo Chen; Hongcai Wang
Journal:  Front Mol Biosci       Date:  2022-07-07

7.  Predictive and discriminative localization of pathology using high resolution class activation maps with CNNs.

Authors:  Sumeet Shinde; Priyanka Tupe-Waghmare; Tanay Chougule; Jitender Saini; Madhura Ingalhalikar
Journal:  PeerJ Comput Sci       Date:  2021-07-14

8.  Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Nadya Pyatigorskaya; Clara B Sanz-Morère; Rahul Gaurav; Emma Biondetti; Romain Valabregue; Mathieu Santin; Lydia Yahia-Cherif; Stéphane Lehéricy
Journal:  Front Neurol       Date:  2020-05-28       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.